Ventus Therapeutics Funding: $370M Raised, Series C (2024)
Ventus Therapeutics is based in Montreal, Quebec, Canada. It has raised $370M in total funding. Latest round: Series C.
Ventus Therapeutics funding overview
Ventus Therapeutics is based in Montreal, Quebec, Canada. Ventus Therapeutics has raised $370M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in January 2024. The round record for Ventus Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Andreessen Horowitz, SoftBank, RTW Investments, Access Biotechnology, Google Ventures, Novo Nordisk and 1 others. 7 distinct backers are named across the disclosed rounds.
Ventus Therapeutics at a glance
Total raised
$370M
Latest round
Series C
Latest round date
January 2024
Headquarters
Montreal, Quebec, Canada
Notable investors
Andreessen Horowitz, SoftBank, RTW Investments, Access Biotechnology, Google Ventures, Novo Nordisk, Michael J. Fox Foundation
Frequently asked about Ventus Therapeutics funding
How much has Ventus Therapeutics raised?
Ventus Therapeutics has raised $370M in total disclosed funding across the rounds on record.
Who has invested in Ventus Therapeutics?
Andreessen Horowitz, SoftBank, RTW Investments, Access Biotechnology, Google Ventures, Novo Nordisk are named among the investors backing Ventus Therapeutics.
What was the latest Ventus Therapeutics funding round?
The most recent disclosed round is a Series C, announced in January 2024.
Where is Ventus Therapeutics based?
Ventus Therapeutics is based in Montreal, Quebec, Canada.
When did Ventus Therapeutics last raise?
The last disclosed Ventus Therapeutics round closed in January 2024 at Series C.
Every Ventus Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Montreal at a similar stage.
